Earnings · China A-shares
Shanghai MicuRx Pharmaceutical Co., Ltd. Class A (688373) earnings
Shanghai MicuRx Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit +75.30% year on year, +73.99% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +1.02% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- +75.30%
- Excl. one-offs YoY
- +73.99%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.20% | — |
| 3 days | +1.02% | — |
| 7 days | +2.86% | — |
| 14 days | +2.04% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +0.57%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | -¥47.80M | +75.30% | +73.99% | +25.43% | -0.07 | -26.83% | +1.02% | — | — |
| 2026 interim report | 2026-08-26 | -¥37.57M | +72.91% | +71.87% | +33.69% | -0.06 | -20.39% | -1.70% | -10.53% | -3.53% |
| 2026 Q1 report | 2026-04-29 | -¥21.45M | +65.19% | +63.21% | +26.62% | -0.03 | -11.07% | +1.70% | -21.60% | -22.55% |
| 2025 annual report | 2026-03-28 | -¥241.61M | +45.18% | +45.50% | +8.83% | -0.37 | -75.34% | +5.54% | -10.10% | -19.46% |
| 2025 Q3 report | 2025-10-28 | -¥193.54M | +33.56% | +33.93% | +6.58% | -0.30 | -55.57% | -2.77% | -17.97% | -14.59% |
| 2025 interim report | 2025-08-20 | -¥138.67M | +31.11% | +32.22% | +10.26% | -0.21 | -36.86% | -4.73% | +13.45% | +3.40% |
| 2025 Q1 report | 2025-04-24 | -¥61.63M | +39.66% | +41.17% | +0.61% | -0.09 | -14.97% | +2.20% | +16.22% | +13.94% |
| 2024 annual report | 2025-03-18 | -¥440.72M | -4.65% | -1.14% | +43.51% | -0.67 | -69.35% | +3.29% | +4.68% | +11.66% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.